<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MPE Archives - Myeloma Patients Europe</title>
	<atom:link href="https://www.mpeurope.org/category/mpe/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.mpeurope.org/category/mpe/</link>
	<description></description>
	<lastBuildDate>Wed, 28 Oct 2026 15:43:12 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://www.mpeurope.org/wp-content/uploads/2023/07/logo_MPE-fav-1-150x150.png</url>
	<title>MPE Archives - Myeloma Patients Europe</title>
	<link>https://www.mpeurope.org/category/mpe/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Amen Association promotes shared decision-making across Israel</title>
		<link>https://www.mpeurope.org/amen-association-promotes-shared-decision-making-across-israel/</link>
					<comments>https://www.mpeurope.org/amen-association-promotes-shared-decision-making-across-israel/#respond</comments>
		
		<dc:creator><![CDATA[Adam Davenport]]></dc:creator>
		<pubDate>Tue, 27 Oct 2026 12:43:27 +0000</pubDate>
				<category><![CDATA[MPE]]></category>
		<guid isPermaLink="false">https://www.mpeurope.org/?p=117514</guid>

					<description><![CDATA[<p>Recently, AMEN Association, one of Myeloma Patients Europe&#8217;s (MPE) member organisations in Israel, carried out its &#8220;Changing Direction&#8221; campaign to help people living with myeloma and their families better understand the advanced treatment options available today and feel more confident when participating in treatment decisions alongside their healthcare team. The campaign was delivered in two&#8230;</p>
<p>The post <a href="https://www.mpeurope.org/amen-association-promotes-shared-decision-making-across-israel/">Amen Association promotes shared decision-making across Israel</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="117514" class="elementor elementor-117514" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-c944414 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="c944414" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-edbcf75" data-id="edbcf75" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-d67e9d5 elementor-widget elementor-widget-text-editor" data-id="d67e9d5" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p><style>
a {<br />    text-decoration: none;<br />    color: #464feb;<br />}<br />tr th, tr td {<br />    border: 1px solid #e6e6e6;<br />}<br />tr th {<br />    background-color: #f5f5f5;<br />}<br /></style></p><div><p>Recently, <strong>AMEN Association</strong>, one of <strong>Myeloma Patients Europe&#8217;s (MPE) member organisations</strong> in Israel, carried out its <strong>&#8220;Changing Direction&#8221;</strong> campaign to help people living with myeloma and their families better understand the advanced treatment options available today and feel more confident when participating in treatment decisions alongside their healthcare team.</p><p>The campaign was delivered in two phases. The first phase ran for approximately one month, from mid-July to mid-August 2026. The second phase began on 23 September 2026 and included around two weeks of radio activity followed by two weeks of digital outreach. </p><p>The campaign was supported by a dedicated content hub on the association&#8217;s website, bringing together clear information about myeloma and current treatment options, personal stories from patients, and expert insights from physicians. Topics covered included shared decision-making, tailoring treatment to individual patient needs, and recent developments in myeloma care.</p><p>As part of the initiative, AMEN also organised a series of webinars for patients and their families. These sessions provided opportunities to learn more about myeloma, ask questions, and gain a deeper understanding of the issues that matter most to them. The association believes that access to reliable and accessible information helps patients become more active partners in managing their disease.</p><p>AMEN&#8217;s work reflects MPE&#8217;s commitment to patient-centred care and shared decision-making. During a month that also includes Blood Cancer Awareness Month and <strong>European Myeloma Day</strong>, initiatives such as &#8220;Changing Direction&#8221; help raise awareness of myeloma while empowering patients to play an informed role in decisions about their treatment and care.</p></div>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-4f703b0 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="4f703b0" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-fbe0104" data-id="fbe0104" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-13112fc elementor-widget elementor-widget-the7_photo-scroller" data-id="13112fc" data-element_type="widget" data-e-type="widget" data-widget_type="the7_photo-scroller.default">
				<div class="elementor-widget-container">
							<div class="photo-scroller the7_photo-scroller-13112fc fullscreen-on hide-thumbs" data-scale="fill" data-autoslide="false" data-play-on-hover="false" data-delay="5000" data-show-thumbnails="true" data-thumb-position="inside-hidden" data-thumb-height="60" data-thumb-width="60" data-thumb-space="5" data-thumb-padding-top="5" data-thumb-padding-bottom="5" data-cntr-space-bottom="5" data-transparency="0.15" data-arrows="true" data-arrows_tablet="true" data-arrows_mobile="true" data-next-icon="fas fa-chevron-right" data-prev-icon="fas fa-chevron-left" data-r-arrow-v-position="center" data-r-arrow-h-position="right" data-l-arrow-v-position="center" data-l-arrow-h-position="left" data-ls-fill-dt="fill" data-ls-fill-tablet="fill" data-pt-fill-dt="fit" data-pt-fill-tablet="fit" data-pt-fill-mob="fit" data-ls-fill-mob="fill" data-padding-top="0" data-padding-bottom="0" data-padding-side="0" data-padding-left="0" data-t-padding-top="0" data-t-padding-bottom="0" data-t-padding-side="0" data-t-padding-left="0" data-m-padding-top="0" data-m-padding-bottom="0" data-m-padding-side="0" data-m-padding-left="0" data-ls-max="100" data-t-ls-max="100" data-m-ls-max="100" data-ls-min="0" data-t-ls-min="0" data-m-ls-min="0" data-pt-max="100" data-t-pt-max="100" data-m-pt-max="100" data-pt-min="0" data-t-pt-min="0" data-m-pt-min="0" data-height="300" data-tablet-height="300" data-mobile-height="300">
			<div class="photoSlider ">
				<figure data-width="248" data-height="422"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/1.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/1.png" class="post-thumbnail-rollover layzr-bg" title="1"  aria-label="Post image"><img fetchpriority="high" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20248%20422&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/1.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/1.png 248w" loading="eager" style="--ratio: 248 / 422" sizes="(max-width: 248px) 100vw, 248px" class="preload-me photo-thumb-lazy-load aspect" width="248" height="422"  alt="1" title="1" /></a></a></figure><figure data-width="457" data-height="808"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/2.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/2.png" class="post-thumbnail-rollover layzr-bg" title="2"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20457%20808&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/2.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/2.png 457w" loading="eager" style="--ratio: 457 / 808" sizes="(max-width: 457px) 100vw, 457px" class="preload-me photo-thumb-lazy-load aspect" width="457" height="808"  alt="2" title="2" /></a></a></figure><figure data-width="246" data-height="418"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/3.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/3.png" class="post-thumbnail-rollover layzr-bg" title="3"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20246%20418&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/3.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/3.png 246w" loading="eager" style="--ratio: 246 / 418" sizes="(max-width: 246px) 100vw, 246px" class="preload-me photo-thumb-lazy-load aspect" width="246" height="418"  alt="3" title="3" /></a></a></figure><figure data-width="241" data-height="412"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/4.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/4.png" class="post-thumbnail-rollover layzr-bg" title="4"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20241%20412&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/4.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/4.png 241w" loading="eager" style="--ratio: 241 / 412" sizes="(max-width: 241px) 100vw, 241px" class="preload-me photo-thumb-lazy-load aspect" width="241" height="412"  alt="4" title="4" /></a></a></figure><figure data-width="241" data-height="423"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/5.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/5.png" class="post-thumbnail-rollover layzr-bg" title="5"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20241%20423&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/5.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/5.png 241w" loading="eager" style="--ratio: 241 / 423" sizes="(max-width: 241px) 100vw, 241px" class="preload-me photo-thumb-lazy-load aspect" width="241" height="423"  alt="5" title="5" /></a></a></figure><figure data-width="241" data-height="436"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/6.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/6.png" class="post-thumbnail-rollover layzr-bg" title="6"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20241%20436&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/6.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/6.png 241w" loading="eager" style="--ratio: 241 / 436" sizes="(max-width: 241px) 100vw, 241px" class="preload-me photo-thumb-lazy-load aspect" width="241" height="436"  alt="6" title="6" /></a></a></figure><figure data-width="245" data-height="435"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/7.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/7.png" class="post-thumbnail-rollover layzr-bg" title="7"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20245%20435&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/7.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/7.png 245w" loading="eager" style="--ratio: 245 / 435" sizes="(max-width: 245px) 100vw, 245px" class="preload-me photo-thumb-lazy-load aspect" width="245" height="435"  alt="7" title="7" /></a></a></figure><figure data-width="244" data-height="398"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/8.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/8.png" class="post-thumbnail-rollover layzr-bg" title="8"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20244%20398&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/8.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/8.png 244w" loading="eager" style="--ratio: 244 / 398" sizes="(max-width: 244px) 100vw, 244px" class="preload-me photo-thumb-lazy-load aspect" width="244" height="398"  alt="8" title="8" /></a></a></figure>			</div>
			<div class="btn-cntr">
				<a href="#" class="hide-thumb-btn"></a>
				<a href="#" class="auto-play-btn"></a>
				<a href="#" class="full-screen-btn"></a>
			</div>
			<div class="scroller-arrow prev" role="button" tabindex="0" aria-label="Prev slide"><i aria-hidden="true" class="fas fa-chevron-left"></i></div>
			<div class="scroller-arrow next"  role="button" tabindex="0" aria-label="Next slide"><i aria-hidden="true" class="fas fa-chevron-right"></i></div>
		</div>
						</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://www.mpeurope.org/amen-association-promotes-shared-decision-making-across-israel/">Amen Association promotes shared decision-making across Israel</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.mpeurope.org/amen-association-promotes-shared-decision-making-across-israel/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>MPE members drive myeloma awareness across Europe during EMD and BCAM</title>
		<link>https://www.mpeurope.org/mpe-members-drive-myeloma-awareness-across-europe-during-emd-and-bcam/</link>
					<comments>https://www.mpeurope.org/mpe-members-drive-myeloma-awareness-across-europe-during-emd-and-bcam/#respond</comments>
		
		<dc:creator><![CDATA[Adam Davenport]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 08:09:10 +0000</pubDate>
				<category><![CDATA[MPE]]></category>
		<guid isPermaLink="false">https://www.mpeurope.org/?p=117259</guid>

					<description><![CDATA[<p>September proved to be an extraordinary month for myeloma advocacy across MPE&#8217;s member network. Our members delivered bold, impactful campaigns to raise awareness during Blood Cancer Awareness Month (BCAM) and European Myeloma Day (EMD) on 27 September.</p>
<p>The post <a href="https://www.mpeurope.org/mpe-members-drive-myeloma-awareness-across-europe-during-emd-and-bcam/">MPE members drive myeloma awareness across Europe during EMD and BCAM</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="117259" class="elementor elementor-117259" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-5b78da4 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="5b78da4" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-105b47c" data-id="105b47c" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-490a8d8 elementor-widget elementor-widget-text-editor" data-id="490a8d8" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p><span style="font-family: lato, helvetica neue, helvetica, arial, sans-serif;">September proved to be an extraordinary month for myeloma advocacy across MPE&#8217;s member network. Our members delivered bold, impactful campaigns to raise awareness during Blood Cancer Awareness Month (BCAM) and European Myeloma Day (EMD) on 27 September.</span></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-650788a elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="650788a" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a57ace3" data-id="a57ace3" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-210bc24 elementor-widget elementor-widget-the7_photo-scroller" data-id="210bc24" data-element_type="widget" data-e-type="widget" data-widget_type="the7_photo-scroller.default">
				<div class="elementor-widget-container">
							<div class="photo-scroller the7_photo-scroller-210bc24 fullscreen-on hide-thumbs" data-scale="fill" data-autoslide="false" data-play-on-hover="false" data-delay="5000" data-show-thumbnails="true" data-thumb-position="inside-hidden" data-thumb-height="60" data-thumb-width="60" data-thumb-space="5" data-thumb-padding-top="5" data-thumb-padding-bottom="5" data-cntr-space-bottom="5" data-transparency="0.15" data-arrows="true" data-arrows_tablet="true" data-arrows_mobile="true" data-next-icon="fas fa-chevron-right" data-prev-icon="fas fa-chevron-left" data-r-arrow-v-position="center" data-r-arrow-h-position="right" data-l-arrow-v-position="center" data-l-arrow-h-position="left" data-ls-fill-dt="fill" data-ls-fill-tablet="fill" data-pt-fill-dt="fit" data-pt-fill-tablet="fit" data-pt-fill-mob="fit" data-ls-fill-mob="fill" data-padding-top="0" data-padding-bottom="0" data-padding-side="0" data-padding-left="0" data-t-padding-top="0" data-t-padding-bottom="0" data-t-padding-side="0" data-t-padding-left="0" data-m-padding-top="0" data-m-padding-bottom="0" data-m-padding-side="0" data-m-padding-left="0" data-ls-max="100" data-t-ls-max="100" data-m-ls-max="100" data-ls-min="0" data-t-ls-min="0" data-m-ls-min="0" data-pt-max="100" data-t-pt-max="100" data-m-pt-max="100" data-pt-min="0" data-t-pt-min="0" data-m-pt-min="0" data-height="300" data-tablet-height="300" data-mobile-height="300">
			<div class="photoSlider ">
				<figure data-width="558" data-height="356"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-112724.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-112724.png" class="post-thumbnail-rollover layzr-bg" title="Sharing the MPE Myeloma Diagnosis Pathway"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20558%20356&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-112724.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-112724.png 558w" loading="eager" style="--ratio: 558 / 356" sizes="(max-width: 558px) 100vw, 558px" class="preload-me photo-thumb-lazy-load aspect" width="558" height="356"  alt="Screenshot 2026 10 02 112724" title="Sharing the MPE Myeloma Diagnosis Pathway" /></a></a></figure><figure data-width="490" data-height="656"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-112753.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-112753.png" class="post-thumbnail-rollover layzr-bg" title="Campaigning in Serbia"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20490%20656&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-112753.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-112753.png 490w" loading="eager" style="--ratio: 490 / 656" sizes="(max-width: 490px) 100vw, 490px" class="preload-me photo-thumb-lazy-load aspect" width="490" height="656"  alt="Campaigning in Serbia" title="Campaigning in Serbia" /></a></a></figure><figure data-width="743" data-height="928"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-113948.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-113948.png" class="post-thumbnail-rollover layzr-bg" title="Supporting EMD in Israel"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20743%20928&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-113948.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-02-113948.png 743w" loading="eager" style="--ratio: 743 / 928" sizes="(max-width: 743px) 100vw, 743px" class="preload-me photo-thumb-lazy-load aspect" width="743" height="928"  alt="Supporting EMD in Israel" title="Supporting EMD in Israel" /></a></a></figure><figure data-width="739" data-height="919"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-085535.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-085535.png" class="post-thumbnail-rollover layzr-bg" title="Screenshot 2026 10 06 085535"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20739%20919&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-085535.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-085535.png 739w" loading="eager" style="--ratio: 739 / 919" sizes="(max-width: 739px) 100vw, 739px" class="preload-me photo-thumb-lazy-load aspect" width="739" height="919"  alt="Screenshot 2026 10 06 085535" title="Screenshot 2026 10 06 085535" /></a></a></figure><figure data-width="927" data-height="558"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-093610.png "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-093610.png" class="post-thumbnail-rollover layzr-bg" title="Screenshot 2026 10 06 093610"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20927%20558&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-093610.png" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-093610.png 927w" loading="eager" style="--ratio: 927 / 558" sizes="(max-width: 927px) 100vw, 927px" class="preload-me photo-thumb-lazy-load aspect" width="927" height="558"  alt="Screenshot 2026 10 06 093610" title="Screenshot 2026 10 06 093610" /></a></a></figure><figure data-width="2560" data-height="1705"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/Sal_Alice_II-scaled.jpeg "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/Sal_Alice_II-scaled.jpeg" class="post-thumbnail-rollover layzr-bg" title="Sál Alice II"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%202560%201705&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/Sal_Alice_II-scaled.jpeg" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/Sal_Alice_II-scaled.jpeg 2560w" loading="eager" style="--ratio: 2560 / 1705" sizes="(max-width: 2560px) 100vw, 2560px" class="preload-me photo-thumb-lazy-load aspect" width="2560" height="1705"  alt="Sál Alice II - Czech Rep" title="Sál Alice II" /></a></a></figure><figure data-width="1705" data-height="2560"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/Brozury_I-scaled.jpeg "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/Brozury_I-scaled.jpeg" class="post-thumbnail-rollover layzr-bg" title="Brožury I"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%201705%202560&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/Brozury_I-scaled.jpeg" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/Brozury_I-scaled.jpeg 1705w" loading="eager" style="--ratio: 1705 / 2560" sizes="(max-width: 1705px) 100vw, 1705px" class="preload-me photo-thumb-lazy-load aspect" width="1705" height="2560"  alt="Brožury I - Czech Rep" title="Brožury I" /></a></a></figure><figure data-width="1705" data-height="2560"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/Jakub-scaled.jpeg "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/Jakub-scaled.jpeg" class="post-thumbnail-rollover layzr-bg" title="Jakub"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%201705%202560&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/Jakub-scaled.jpeg" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/Jakub-scaled.jpeg 1705w" loading="eager" style="--ratio: 1705 / 2560" sizes="(max-width: 1705px) 100vw, 1705px" class="preload-me photo-thumb-lazy-load aspect" width="1705" height="2560"  alt="Jakub Czech Rep" title="Jakub" /></a></a></figure><figure data-width="2560" data-height="1705"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/10/Sal_Sasa-scaled.jpeg "<a href="https://www.mpeurope.org/wp-content/uploads/2026/10/Sal_Sasa-scaled.jpeg" class="post-thumbnail-rollover layzr-bg" title="Sál Saša"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%202560%201705&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/10/Sal_Sasa-scaled.jpeg" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/Sal_Sasa-scaled.jpeg 2560w" loading="eager" style="--ratio: 2560 / 1705" sizes="(max-width: 2560px) 100vw, 2560px" class="preload-me photo-thumb-lazy-load aspect" width="2560" height="1705"  alt="Sál Saša - Czech Rep" title="Sál Saša" /></a></a></figure>			</div>
			<div class="btn-cntr">
				<a href="#" class="hide-thumb-btn"></a>
				<a href="#" class="auto-play-btn"></a>
				<a href="#" class="full-screen-btn"></a>
			</div>
			<div class="scroller-arrow prev" role="button" tabindex="0" aria-label="Prev slide"><i aria-hidden="true" class="fas fa-chevron-left"></i></div>
			<div class="scroller-arrow next"  role="button" tabindex="0" aria-label="Next slide"><i aria-hidden="true" class="fas fa-chevron-right"></i></div>
		</div>
						</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-e9b81b9 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="e9b81b9" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4a762f2" data-id="4a762f2" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-e4d0695 elementor-widget elementor-widget-text-editor" data-id="e4d0695" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<h3><strong>Raising public awareness</strong></h3><p>Across Europe, members used creative and high-profile campaigns to put myeloma in the spotlight. <strong>Slovenia’s Društvo BKB</strong> delivered its most comprehensive campaign yet, combining press conferences, hospital information stands, a “Walk in Red” event and a photography competition. In<strong> Poland, Fundacja Carita</strong> hosted its 6th Annual Health Rally, bringing together more than 800 patients, advocates and healthcare providers to raise awareness of myeloma and other blood disorders.</p><p><strong>Serbia’s Association of Myeloma Patients Serbia (AMPS)</strong> took awareness nationwide with an EMD event and caravan campaign, while <strong>Portugal’s Associação Portuguesa Contra a Leucemia (APCL</strong>) ran a month-long campaign of activities focused on blood cancer awareness.</p><h3><strong>Improving diagnosis and engaging healthcare professionals</strong></h3><p>Several members focused on improving awareness and understanding of myeloma among healthcare professionals. In Serbia, the caravan campaign distributed the myeloma diagnosis pathway to GPs, while <strong>Lithuania’s Kraujas</strong> published the MPE Myeloma Diagnosis Pathway on a digital platform accessed by more than 5,000 GPs.</p><p><strong>Educating and empowering patients</strong></p><p>Patient education remained a strong focus throughout the month. <strong>Russia’s Mercy Bridge </strong>hosted a Patient School covering diagnosis, innovative therapies and supportive care, while the <strong>Czech Republic’s Klub pacientů mnohočetný myelom (KPMM)</strong> hosted a two-day patient seminar.<br />In Portugal, APCL’s month-long programme included specialist seminars and a survivorship conference, providing opportunities for patients and others in the myeloma community to access information and share experiences.</p><h3><strong>Supporting the myeloma community</strong></h3><p>Members also created opportunities for people affected by myeloma to connect, learn and support one another. <strong>Multiple Myeloma Ireland</strong> brought the community together through its “Living Well with Myeloma” event, which welcomed more than 70 myeloma patients, carers and advocates.</p><p>Together, these campaigns reflect the dedication of our members to putting myeloma on the European health agenda, from public awareness to clinician engagement to advocating for access to innovative treatments.</p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-5d713dc elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="5d713dc" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-c9f84c3" data-id="c9f84c3" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-36b16cc elementor-widget elementor-widget-image" data-id="36b16cc" data-element_type="widget" data-e-type="widget" data-widget_type="image.default">
				<div class="elementor-widget-container">
															<img decoding="async" width="768" height="462" src="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-093610-768x462.png" class="attachment-medium_large size-medium_large wp-image-117272" alt="Screenshot 2026 10 06 093610" srcset="https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-093610-768x462.png 768w, https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-093610-300x181.png 300w, https://www.mpeurope.org/wp-content/uploads/2026/10/Screenshot-2026-10-06-093610.png 927w" sizes="(max-width: 768px) 100vw, 768px" />															</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://www.mpeurope.org/mpe-members-drive-myeloma-awareness-across-europe-during-emd-and-bcam/">MPE members drive myeloma awareness across Europe during EMD and BCAM</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.mpeurope.org/mpe-members-drive-myeloma-awareness-across-europe-during-emd-and-bcam/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>MPE strengthens patient voice in cancer quality-of-life research at EORTC meeting</title>
		<link>https://www.mpeurope.org/mpe-strengthens-patient-voice-in-cancer-quality-of-life-research-at-eortc-meeting/</link>
					<comments>https://www.mpeurope.org/mpe-strengthens-patient-voice-in-cancer-quality-of-life-research-at-eortc-meeting/#respond</comments>
		
		<dc:creator><![CDATA[Adam Davenport]]></dc:creator>
		<pubDate>Thu, 01 Oct 2026 12:12:29 +0000</pubDate>
				<category><![CDATA[Conferences]]></category>
		<category><![CDATA[MPE]]></category>
		<category><![CDATA[Sin categoría]]></category>
		<guid isPermaLink="false">https://www.mpeurope.org/?p=117213</guid>

					<description><![CDATA[<p>Last week MPE was in Zagreb for the Autumn EORTC Quality of Life Group meeting, connecting with colleagues working to strengthen the role of quality-of-life data in cancer research. The EORTC is the European Organisation for Research and Treatment of Cancer, a cancer research organisation that brings people together to answer important questions about which&#8230;</p>
<p>The post <a href="https://www.mpeurope.org/mpe-strengthens-patient-voice-in-cancer-quality-of-life-research-at-eortc-meeting/">MPE strengthens patient voice in cancer quality-of-life research at EORTC meeting</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="117213" class="elementor elementor-117213" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-7977c0e elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="7977c0e" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0ba2608" data-id="0ba2608" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-a5cb043 elementor-widget elementor-widget-text-editor" data-id="a5cb043" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p dir="ltr">Last week MPE was in Zagreb for the Autumn EORTC Quality of Life Group meeting, connecting with colleagues working to strengthen the role of quality-of-life data in cancer research.</p><p dir="ltr">The <a href="https://www.eortc.org/" target="_blank" rel="noopener">EORTC is the European Organisation for Research and Treatment of Cancer</a>, a cancer research organisation that brings people together to answer important questions about which cancer treatments work best and what their impact is on patients&#8217; lives. The Quality of Life group focuses on measuring and understanding patients&#8217; quality of life in cancer research.</p><p dir="ltr">Ahead of the official meeting, MPE&#8217;s Board Member Vincent Claus contributed to the pilot in-person SISAQOL training course. SISAQOL was a collaborative project that developed recommendations for designing, analysing, presenting and interpreting patient-reported data in cancer clinical trials. MPE was a work package lead on this European Union-funded project. Over the training course, participants learned and discussed how to apply the SISAQOL project recommendations.</p><p dir="ltr">MPE&#8217;s Head of Patient Research, Eilidh Duncan, attended the two-day in-person Quality of Life group meeting and represents MPE on a number of active projects within the group. These projects include the development of measures to capture patients&#8217; experiences of T-cell engaging immunotherapies and to understand the impact of cancer and treatments on finances.</p><p dir="ltr">The meeting and discussions provide an important opportunity to bring the perspectives of the patient community and patient advocates into the group&#8217;s work. It also enables MPE to learn from others and share this learning with our members and community on new developments and best practices in quality of life measurement, analysis and interpretation.</p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://www.mpeurope.org/mpe-strengthens-patient-voice-in-cancer-quality-of-life-research-at-eortc-meeting/">MPE strengthens patient voice in cancer quality-of-life research at EORTC meeting</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.mpeurope.org/mpe-strengthens-patient-voice-in-cancer-quality-of-life-research-at-eortc-meeting/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Highlights from the International Myeloma Society (IMS) annual meeting</title>
		<link>https://www.mpeurope.org/highlights-from-the-international-myeloma-society-ims-annual-meeting/</link>
					<comments>https://www.mpeurope.org/highlights-from-the-international-myeloma-society-ims-annual-meeting/#respond</comments>
		
		<dc:creator><![CDATA[Adam Davenport]]></dc:creator>
		<pubDate>Wed, 30 Sep 2026 14:06:51 +0000</pubDate>
				<category><![CDATA[Conferences]]></category>
		<category><![CDATA[MPE]]></category>
		<category><![CDATA[CERVINO]]></category>
		<category><![CDATA[EXCALIBER-RRMM]]></category>
		<category><![CDATA[IMS highlights]]></category>
		<guid isPermaLink="false">https://www.mpeurope.org/?p=117182</guid>

					<description><![CDATA[<p>From September 23-26, Myeloma Patients Europe (MPE) attended the 23rd International Myeloma Society (IMS) Annual Meeting in Glasgow, Scotland. The IMS Annual Meeting is one of the most important international conferences for myeloma researchers and healthcare professionals, bringing together experts to discuss basic science, preclinical research and clinical developments in myeloma. More than 3,000 people&#8230;</p>
<p>The post <a href="https://www.mpeurope.org/highlights-from-the-international-myeloma-society-ims-annual-meeting/">Highlights from the International Myeloma Society (IMS) annual meeting</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="117182" class="elementor elementor-117182" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-8897e54 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="8897e54" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8bfd88f" data-id="8bfd88f" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-4586325 elementor-widget elementor-widget-text-editor" data-id="4586325" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p><span data-contrast="auto">From September 23-26, Myeloma Patients Europe (MPE) attended the 23rd International Myeloma Society (IMS) Annual Meeting in Glasgow, Scotland. The IMS Annual Meeting is one of the most important international conferences for myeloma researchers and healthcare professionals, bringing together experts to discuss basic science, preclinical research and clinical developments in myeloma. More than 3,000 people from over 75 countries attended this year’s meeting.</span><span data-ccp-props="{}"> </span></p><p><span data-contrast="auto">MPE was there to learn about the latest developments in myeloma treatment, diagnosis and monitoring, and to make sure that patients’ perspectives and priorities are represented in discussions about the future of myeloma care. Here are some of the highlights we took away from this year&#8217;s meeting:</span><span data-ccp-props="{}"> </span></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-ba96bb1 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="ba96bb1" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-cdd000f" data-id="cdd000f" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-8a4eba6 elementor-widget elementor-widget-heading" data-id="8a4eba6" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h4 class="elementor-heading-title elementor-size-default">Looking at the whole person </h4>				</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-1ec3f1c elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="1ec3f1c" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a194fc6" data-id="a194fc6" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-0d958c6 elementor-widget elementor-widget-text-editor" data-id="0d958c6" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p>The Nursing and allied health symposium had a strong focus on the importance of quality of life and understanding what matters to patients.</p><p>One key message was that a frailty score alone does not always give a complete picture of someone&#8217;s health. A full geriatric assessment can consider areas such as mobility, mood and ability to carry out everyday activities, helping healthcare teams identify areas where support could help. The symposium emphasized listening to patients, as healthcare professionals may underestimate symptom severity. Patient-reported outcome measures (PROMs) can help healthcare teams and researchers understand the impact of myeloma and its treatments more fully.</p><p>We also heard how, as treatments become increasingly effective, health-related quality of life and PROMs will become increasingly important in clinical trials. We want to see clinical trials place greater emphasis on what matters to patients, including symptoms, side effects and how treatments affect everyday life, particularly when treatments offer similar levels of disease control.</p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-cddba0f elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="cddba0f" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4b2a6d9" data-id="4b2a6d9" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-92bf623 elementor-widget elementor-widget-heading" data-id="92bf623" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h4 class="elementor-heading-title elementor-size-default">Blood tests for diagnosing and monitoring myeloma  </h4>				</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-48dca87 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="48dca87" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3540fc8" data-id="3540fc8" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-85d943a elementor-widget elementor-widget-text-editor" data-id="85d943a" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p><span data-contrast="auto">There was a lot of interest in new blood-based technologies for diagnosing and monitoring myeloma. Many aspects of disease monitoring, including assessing treatment response and minimal residual disease (MRD), currently involve collecting a bone marrow sample through a biopsy. People living with myeloma can have negative experiences of bone marrow biopsies, so there is interest in whether blood-based approaches could make monitoring easier and improve quality of life.</span><span data-ccp-props="{}"> </span></p><p><span data-contrast="auto">Several approaches are being studied, including looking for circulating tumour cells, using mass spectrometry to detect very small amounts of paraprotein, and analysing circulating tumour DNA. These techniques may help detect very small amounts of disease, assess risk and monitor treatment response. However, most blood-based approaches are not yet ready to replace bone marrow testing, which remains the gold standard test.</span><span data-ccp-props="{}"> </span></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-c352f9a elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="c352f9a" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-ecb4db6" data-id="ecb4db6" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-0154bca elementor-widget elementor-widget-heading" data-id="0154bca" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h4 class="elementor-heading-title elementor-size-default">Preventing infections and side effects </h4>				</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-ff9ec45 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="ff9ec45" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a7db0e8" data-id="a7db0e8" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-759e3b6 elementor-widget elementor-widget-text-editor" data-id="759e3b6" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p><span data-contrast="auto">A key message from the meeting was that infection risk changes over time and is different for different treatments. Rather than using a one-size-fits-all approach, healthcare teams are increasingly looking at how immune function, blood counts and other risk factors can be used to tailor infection prevention to each person.</span><span data-ccp-props="{}"> </span></p><p><span data-contrast="auto">There was also discussion about whether adjusting treatment schedules, including reducing how often some treatments are given or using fixed-duration treatment, could reduce the risk of infections and other side effects while maintaining treatment benefits.</span></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-c9ee42d elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="c9ee42d" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8d4c14b" data-id="8d4c14b" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-6eb8833 elementor-widget elementor-widget-heading" data-id="6eb8833" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h4 class="elementor-heading-title elementor-size-default">Developments in myeloma treatment </h4>				</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-3619901 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="3619901" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2a2da28" data-id="2a2da28" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-0defb71 elementor-widget elementor-widget-text-editor" data-id="0defb71" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p>Treatment developments were another important part of the meeting, with new results highlighting advances in both relapsed/refractory and newly diagnosed myeloma. Of note:</p><p>The <strong>CERVINO</strong> clinical trial showed that the investigational bispecific antibody etentamig improved response rates and helped people stay free from worsening myeloma for longer, compared with standard available treatments in people whose myeloma had already been exposed to three major classes of treatment. The treatment was given once every four weeks, which is more convenient for patients than the more frequent dosing schedules used for some other bispecific antibodies. Watch our interview explaining the outcomes of the CERVINO clinical trial.</p><p><span class="TextRun SCXW251682662 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW251682662 BCX8">The </span></span><strong><span class="TextRun SCXW251682662 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW251682662 BCX8">EXCALIBER-RRMM</span></span></strong><span class="TextRun SCXW251682662 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"> <span class="NormalTextRun SCXW251682662 BCX8">clinical trial </span><span class="NormalTextRun SCXW251682662 BCX8">found that </span><span class="NormalTextRun SpellingErrorV2Themed SCXW251682662 BCX8">iberdomide</span><span class="NormalTextRun SCXW251682662 BCX8">, a newer type of immunomodulatory drug, combined with daratumumab and dexamethasone led to deeper responses than daratumumab, </span><span class="NormalTextRun SCXW251682662 BCX8">bortezomib</span><span class="NormalTextRun SCXW251682662 BCX8"> and dexamethasone in people with relapsed or refractory myeloma.</span><span class="NormalTextRun SCXW251682662 BCX8"> There were more problems with low levels of neutrophils </span><span class="NormalTextRun SCXW251682662 BCX8">(neutropenia) </span><span class="NormalTextRun SCXW251682662 BCX8">and infections with the </span><span class="NormalTextRun SpellingErrorV2Themed SCXW251682662 BCX8">iberdomide</span><span class="NormalTextRun SCXW251682662 BCX8"> combination, but nerve damage (peripheral neuropathy) was less common.</span> Watch our interview explaining the EXCALIBER-RRMM clinical trial.</span><span class="EOP Selected SCXW251682662 BCX8" data-ccp-props="{}"> </span></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-0ad4a39 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="0ad4a39" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-164ea96" data-id="164ea96" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-14001b3 elementor-widget elementor-widget-video" data-id="14001b3" data-element_type="widget" data-e-type="widget" data-settings="{&quot;youtube_url&quot;:&quot;https:\/\/youtu.be\/rSbclS53uTg?si=aewmS6Od_0dR-I-k&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}" data-widget_type="video.default">
				<div class="elementor-widget-container">
							<div class="elementor-wrapper elementor-open-inline">
			<div class="elementor-video"></div>		</div>
						</div>
				</div>
					</div>
		</div>
				<div class="elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-0230dde" data-id="0230dde" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-3c84867 elementor-widget elementor-widget-video" data-id="3c84867" data-element_type="widget" data-e-type="widget" data-settings="{&quot;youtube_url&quot;:&quot;https:\/\/youtu.be\/00A6iYKwRG0?si=-IzxMy-kCJIkjr5i&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}" data-widget_type="video.default">
				<div class="elementor-widget-container">
							<div class="elementor-wrapper elementor-open-inline">
			<div class="elementor-video"></div>		</div>
						</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-3e99d87 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="3e99d87" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-22e469e" data-id="22e469e" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-ed69d5d elementor-widget elementor-widget-heading" data-id="ed69d5d" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h4 class="elementor-heading-title elementor-size-default">MPE at IMS</h4>				</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-142d863 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="142d863" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f6ac68e" data-id="f6ac68e" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-b9fada3 elementor-widget elementor-widget-text-editor" data-id="b9fada3" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p><span data-contrast="auto">We were pleased to share MPE&#8217;s research at the meeting: </span><span data-ccp-props="{}"> </span></p><p><span data-contrast="auto">We presented a poster on how myeloma clinical trials can better include people from groups that are often underrepresented in research.  It is important that clinical trials include the wide range of people affected by myeloma, so that new treatments work well for different people and communities and can be trusted by those who use them. Our research found that many approaches to making clinical research more inclusive were developed in the US. While these have often focused on improving inclusion across different ethnic groups, other factors that can affect someone’s opportunity to take part, such as mental health and their ability to give informed consent have received less attention. The approaches may therefore need to be adapted to ensure they are relevant to patients across Europe.</span><span data-ccp-props="{}"> </span></p><p><span data-contrast="auto">We also took part in the </span><b><span data-contrast="auto">first ever patient group session at IMS</span></b><span data-contrast="auto">, where we had the opportunity to share MPE&#8217;s priorities and our work to improve access to treatment and care across Europe, alongside other international patient organisations. We are grateful to the IMS for creating opportunities for patient organisations to be part of these discussions. As MPE Co-CEO Kate Morgan said during the meeting:</span><span data-ccp-props="{}"> </span></p><p><em><strong>“We need to be working not just with other patient organisations but also with the IMS, industry and academic groups to tackle the shared challenges in myeloma and to bring the innovation we’ve seen this weekend to patients globally.” </strong></em></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-4ae35ac elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="4ae35ac" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f13bbf8" data-id="f13bbf8" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-3ccdf45 elementor-widget elementor-widget-heading" data-id="3ccdf45" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h4 class="elementor-heading-title elementor-size-default">Looking ahead</h4>				</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-ab55af0 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="ab55af0" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e83133c" data-id="e83133c" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-b024b11 elementor-widget elementor-widget-text-editor" data-id="b024b11" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p><span data-contrast="auto">For MPE, the important question is </span><b><span data-contrast="auto">not only what new treatments can achieve, but also what the experience of receiving those treatments is like for patients</span></b><span data-contrast="auto">. Treatments need to be effective, but they also need to fit into people&#8217;s lives, support quality of life and be accessible to the people who need them.</span><span data-ccp-props="{}"> </span></p><p><span data-contrast="auto">If you have any questions or comments about IMS 2026, please contact </span><a href="mailto:info@mpeurope.org"><span data-contrast="none">info@mpeurope.org</span></a></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://www.mpeurope.org/highlights-from-the-international-myeloma-society-ims-annual-meeting/">Highlights from the International Myeloma Society (IMS) annual meeting</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.mpeurope.org/highlights-from-the-international-myeloma-society-ims-annual-meeting/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Dr. Faith Davies interview on IMS 2026</title>
		<link>https://www.mpeurope.org/prof-faith-davies-interview-on-ims-2026/</link>
					<comments>https://www.mpeurope.org/prof-faith-davies-interview-on-ims-2026/#respond</comments>
		
		<dc:creator><![CDATA[Adam Davenport]]></dc:creator>
		<pubDate>Thu, 17 Sep 2026 13:04:55 +0000</pubDate>
				<category><![CDATA[Conferences]]></category>
		<category><![CDATA[MPE]]></category>
		<category><![CDATA[Myeloma]]></category>
		<guid isPermaLink="false">https://www.mpeurope.org/?p=117047</guid>

					<description><![CDATA[<p>As the International Myeloma Society (IMS) Annual Meeting is taking place this week, we caught up with myeloma expert Dr. Faith Davies, from NYU Langone, about her expectations for the meeting and why it is important for patient advocacy groups like MPE to attend. What are you looking forward to most about IMS 2026? I&#8230;</p>
<p>The post <a href="https://www.mpeurope.org/prof-faith-davies-interview-on-ims-2026/">Dr. Faith Davies interview on IMS 2026</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="117047" class="elementor elementor-117047" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-8662c99 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="8662c99" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-8949df8" data-id="8949df8" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-d8ee07e elementor-widget elementor-widget-spacer" data-id="d8ee07e" data-element_type="widget" data-e-type="widget" data-widget_type="spacer.default">
				<div class="elementor-widget-container">
							<div class="elementor-spacer">
			<div class="elementor-spacer-inner"></div>
		</div>
						</div>
				</div>
				<div class="elementor-element elementor-element-e22223c elementor-widget elementor-widget-text-editor" data-id="e22223c" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p>As the International Myeloma Society (IMS) Annual Meeting is taking place this week, we caught up with myeloma expert <strong>Dr. Faith Davies, from NYU Langone,</strong> about her expectations for the meeting and why it is important for patient advocacy groups like MPE to attend.</p><h4>What are you looking forward to most about IMS 2026?</h4><p>I am really looking forward to spending four days talking and thinking about myeloma! There has been so much happening in the field recently that concentrating on the new advances will be incredible. IMS gives me chance to think about how I can incorporate the new advances into my own practice, and what the knowledge gaps are for new research.</p><p>The myeloma community is quite small, so the meeting is also great opportunity to meet up with old friends and colleagues. It is often conversations over coffee (or a beer!) that have the greatest impact. For example, hearing how someone has successfully managed a difficult clinical case or learning about a new laboratory technique. </p>								</div>
				</div>
					</div>
		</div>
				<div class="elementor-column elementor-col-66 elementor-top-column elementor-element elementor-element-07dd58d" data-id="07dd58d" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-3edaa18 elementor-widget__width-initial elementor-widget elementor-widget-image" data-id="3edaa18" data-element_type="widget" data-e-type="widget" data-widget_type="image.default">
				<div class="elementor-widget-container">
															<img decoding="async" width="934" height="1024" src="https://www.mpeurope.org/wp-content/uploads/2026/09/Faith-Davies-934x1024.png" class="attachment-large size-large wp-image-117079" alt="Faith Davies" srcset="https://www.mpeurope.org/wp-content/uploads/2026/09/Faith-Davies-934x1024.png 934w, https://www.mpeurope.org/wp-content/uploads/2026/09/Faith-Davies-274x300.png 274w, https://www.mpeurope.org/wp-content/uploads/2026/09/Faith-Davies-768x842.png 768w, https://www.mpeurope.org/wp-content/uploads/2026/09/Faith-Davies-1400x1536.png 1400w, https://www.mpeurope.org/wp-content/uploads/2026/09/Faith-Davies-1867x2048.png 1867w" sizes="(max-width: 934px) 100vw, 934px" />															</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-dc0d91a elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="dc0d91a" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0d231f0" data-id="0d231f0" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-010a2d9 elementor-widget elementor-widget-text-editor" data-id="010a2d9" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<h4><strong>You are chairing the plenary abstract session. What is the key data we will see in this session?</strong></h4><p>It is a real honour to chair the plenary abstract session which showcases some of the most exciting abstracts at the meeting. These abstracts cover important topics such as long-term outcomes for newly diagnosed patients, novel treatments for relapsed patients and new insights on the biology of myeloma.</p><p>Some of the abstracts are reporting their data about the results of clinical trials including data on etentamig, a second-generation BCMA x CD3 bispecific antibody; iberdomide, a CELMOD and an in-vivo dual targeting CART. We also have two more laboratory-based abstracts. One looking at how a protein called NSD2 can be therapeutically targeted in patients with t(4;14) myeloma and another looking at how we can identify ultra high-risk patients who may not respond well to current therapies.</p><h4><strong>What other developments should MPE and our members be paying attention to?</strong></h4><p>A key theme throughout the meeting will be about safety and efficacy of bispecific and CAR T-cell therapies, including a session on infections. There will also be a lot of discussions on the best sequencing of treatments for patients and on side-effect management. For me, it is not yet clear what the best sequences of treatment are for patients, so I am looking forward to hearing people’s views and joining in the lively debates!</p><h4><strong>Why is it important for patient groups like MPE to be involved in IMS?</strong></h4><p>One of the main reasons so much progress has been made in myeloma is the ability of everyone to work together, including researchers, pharmaceutical companies, doctors and nurses, regulatory agencies, patient organisations and patients. It is so important that everyone has a seat at the table particularly as there are so many advances in therapy, many of which have big implications for treating physicians, healthcare utilisation and patient life expectancy. MPE will be able to present their research, learn about new developments and, importantly, share their perspectives on what patients think, need, and value as we move forward together. </p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-b3fce2f elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="b3fce2f" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e8e167d" data-id="e8e167d" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap">
							</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://www.mpeurope.org/prof-faith-davies-interview-on-ims-2026/">Dr. Faith Davies interview on IMS 2026</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.mpeurope.org/prof-faith-davies-interview-on-ims-2026/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Your views and experiences on myeloma, intimacy and sexual wellbeing</title>
		<link>https://www.mpeurope.org/elementor-117034/</link>
					<comments>https://www.mpeurope.org/elementor-117034/#respond</comments>
		
		<dc:creator><![CDATA[Adam Davenport]]></dc:creator>
		<pubDate>Thu, 17 Sep 2026 10:08:47 +0000</pubDate>
				<category><![CDATA[MPE]]></category>
		<category><![CDATA[survey]]></category>
		<guid isPermaLink="false">https://www.mpeurope.org/?p=117034</guid>

					<description><![CDATA[<p>We want to hear from people living with myeloma and their partners about how myeloma or its treatments have affected intimacy or sexual wellbeing and what information would be useful on this topic. Intimacy and sexual wellbeing can be difficult topics to talk about, but they are an important part of quality of life. Myeloma and&#8230;</p>
<p>The post <a href="https://www.mpeurope.org/elementor-117034/">Your views and experiences on myeloma, intimacy and sexual wellbeing</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="117034" class="elementor elementor-117034" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-38d511e elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="38d511e" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-fabee48" data-id="fabee48" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-d8ba060 elementor-widget elementor-widget-text-editor" data-id="d8ba060" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p><span data-contrast="auto">We want to hear from people living with myeloma and their partners about how myeloma or its treatments have affected intimacy or sexual wellbeing and what information would be useful on this topic.</span><span data-ccp-props="{}">&nbsp;</span></p>
<p><span data-contrast="auto">Intimacy and sexual wellbeing can be difficult topics to talk about, but they are an important part of quality of life.&nbsp;Myeloma and its treatments can affect intimacy and sexual wellbeing in physical and emotional ways, yet these issues&nbsp;may not always be discussed with healthcare professionals.</span><span data-ccp-props="{}">&nbsp;</span></p>
<p><span data-contrast="auto">MPE is developing a new educational video about how myeloma and its treatments can affect intimacy and sexual wellbeing. We want the video to address the questions and concerns that matter most to people living with myeloma and their partners.</span><span data-ccp-props="{}">&nbsp;</span></p>
<p><span data-contrast="auto">To help us develop the video, we are inviting people living with myeloma and their partners to complete a&nbsp;</span><span data-contrast="none"><a href="https://forms.cloud.microsoft/e/9DkN8WsQEZ">short online survey</a></span><span data-contrast="auto">. The&nbsp;survey&nbsp;takes&nbsp;approximately&nbsp;</span><b><span data-contrast="auto">5&nbsp;to 10&nbsp;minutes</span></b><span data-contrast="auto">&nbsp;to complete and includes questions about your experiences and what information you&nbsp;are interested in.&nbsp;</span><span data-ccp-props="{}">&nbsp;</span></p>
<p><b><span data-contrast="auto">The survey is completely anonymous. We do not collect your name, email&nbsp;address&nbsp;or any other information that can be used to&nbsp;identify&nbsp;you.</span></b><span data-ccp-props="{}">&nbsp;</span></p>
<p><span data-contrast="auto">Please complete the survey by&nbsp;</span><b><span data-contrast="auto">Monday 5 October 2026</span></b><span data-contrast="auto">.</span><span data-ccp-props="{}">&nbsp;</span></p>
<p><span data-contrast="auto">Your views can help us develop information that reflects the needs of people living with myeloma and their partners. Thank you for taking the time to share your experiences and views.</span><span data-ccp-props="{}">&nbsp;</span></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-3b84006 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="3b84006" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4ae7820" data-id="4ae7820" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-fd28064 elementor-button-info elementor-align-center elementor-widget elementor-widget-button" data-id="fd28064" data-element_type="widget" data-e-type="widget" data-widget_type="button.default">
				<div class="elementor-widget-container">
									<div class="elementor-button-wrapper">
					<a class="elementor-button elementor-button-link elementor-size-sm" href="https://forms.cloud.microsoft/e/9DkN8WsQEZ" target="_blank">
						<span class="elementor-button-content-wrapper">
									<span class="elementor-button-text">Take the survey</span>
					</span>
					</a>
				</div>
								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://www.mpeurope.org/elementor-117034/">Your views and experiences on myeloma, intimacy and sexual wellbeing</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.mpeurope.org/elementor-117034/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Preview to members September activities across Europe</title>
		<link>https://www.mpeurope.org/preview-to-members-september-activities-across-europe/</link>
					<comments>https://www.mpeurope.org/preview-to-members-september-activities-across-europe/#respond</comments>
		
		<dc:creator><![CDATA[Adam Davenport]]></dc:creator>
		<pubDate>Wed, 02 Sep 2026 12:35:36 +0000</pubDate>
				<category><![CDATA[MPE]]></category>
		<guid isPermaLink="false">https://www.mpeurope.org/?p=116850</guid>

					<description><![CDATA[<p>September is shaping up to be an extraordinary month for myeloma awareness and advocacy across MPE&#8217;s member network. From Portugal to Serbia, from Lithuania to Slovenia, our members are planning bold, impactful campaigns to raise awareness during Blood Cancer Awareness Month and European Myeloma Day on 27 September. Key member activities include: Portugal (APCL) is&#8230;</p>
<p>The post <a href="https://www.mpeurope.org/preview-to-members-september-activities-across-europe/">Preview to members September activities across Europe</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="116850" class="elementor elementor-116850" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-468b6db elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="468b6db" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-acae655" data-id="acae655" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-8c06d3b elementor-widget elementor-widget-text-editor" data-id="8c06d3b" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p>September is shaping up to be an extraordinary month for myeloma awareness and advocacy across MPE&#8217;s member network. From Portugal to Serbia, from Lithuania to Slovenia, our members are planning bold, impactful campaigns to raise awareness during Blood Cancer Awareness Month and European Myeloma Day on 27 September.</p><p>Key member activities include:</p><p>Portugal (APCL) is running a full month of engagement: a blood cancer awareness campaign, a specialist seminar on transplant on 12 September and a survivorship conference on 25 September, bringing together patients, carers and clinicians.</p><p>Serbia (AMPS) is taking awareness nationwide with an EMD event on 27 September and a caravan campaign driving across the country, printing and distributing the myeloma diagnosis pathway to reach GPs and primary care physicians at grassroots level.</p><p>Slovenia (Društvo BKB) is running their most comprehensive campaign yet: a press conference, educational lecture, information stands in 12 hospitals, a &#8220;Walk in Red&#8221; awareness event, landmark illuminations, and a photography competition as part of the Capture the Light project.</p><p>Lithuania (Kraujas) is leveraging clinical networks, publishing the MPE Myeloma Diagnosis Pathway on &#8216;FOCUS&#8217; a digital platform accessed by over 5,000 GPs and family doctors, ensuring broad visibility among primary care professionals.</p><p>Russia (Mercy Bridge) is hosting a European Myeloma Day Patient School, an educational event bringing together leading haematology experts to discuss early diagnosis, innovative treatments, and patient support.</p><p>Israel (AMEN) is focusing advocacy on innovative treatments, campaigning to raise awareness of bispecific antibodies and CAR-T therapy and advocating for their inclusion in Israel&#8217;s National Health Basket.</p><p>Czech Republic (KPMM) is hosting a 2-day patient seminar and distributing the diagnosis pathway through GP-focused partner networks.</p><p>These campaigns reflect the breadth of our network and the commitment of our members to putting myeloma and AL amyloidosis on the European health agenda. From public awareness events to clinician engagement, from survivorship support to innovative treatment advocacy, our members are driving real change.</p><p>If you would like to share your member organisation&#8217;s September plans, or if you need support materials for your own BCAM or EMD activities, please get in touch.</p><p>Thank you to all our members for your dedication and leadership!</p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://www.mpeurope.org/preview-to-members-september-activities-across-europe/">Preview to members September activities across Europe</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.mpeurope.org/preview-to-members-september-activities-across-europe/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>A young patient’s experience of induced menopause after myeloma treatment</title>
		<link>https://www.mpeurope.org/a-young-patients-experience-of-induced-menopause-after-myeloma-treatment/</link>
					<comments>https://www.mpeurope.org/a-young-patients-experience-of-induced-menopause-after-myeloma-treatment/#respond</comments>
		
		<dc:creator><![CDATA[Adam Davenport]]></dc:creator>
		<pubDate>Wed, 02 Sep 2026 07:15:40 +0000</pubDate>
				<category><![CDATA[MPE]]></category>
		<category><![CDATA[Patient evidence]]></category>
		<guid isPermaLink="false">https://www.mpeurope.org/?p=116811</guid>

					<description><![CDATA[<p>As part of our September European Young Myeloma Patients Group (EYMPG) meeting on Induced Menopause and Sexual Health in young myeloma patients, Filipa Lopes has shared her personal experience of treatment induced menopause. She was diagnosed with myeloma at the age of 29 and hopes her story encourages other young patients to seek support and&#8230;</p>
<p>The post <a href="https://www.mpeurope.org/a-young-patients-experience-of-induced-menopause-after-myeloma-treatment/">A young patient’s experience of induced menopause after myeloma treatment</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="116811" class="elementor elementor-116811" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-adb9cc8 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="adb9cc8" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-75fe29e" data-id="75fe29e" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-5f5d42e elementor-widget elementor-widget-text-editor" data-id="5f5d42e" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p>As part of our September European Young Myeloma Patients Group (EYMPG) meeting on <strong>Induced Menopause and Sexual Health</strong> <strong>in young myeloma patients</strong>, <strong>Filipa Lopes</strong> has shared her personal experience of treatment induced menopause.</p><p>She was diagnosed with myeloma at the age of 29 and hopes her story encourages other young patients to seek support and know they are not alone.</p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-2e121ec elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="2e121ec" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-d0e88aa" data-id="d0e88aa" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-ee712bc elementor-widget-divider--view-line elementor-widget elementor-widget-divider" data-id="ee712bc" data-element_type="widget" data-e-type="widget" data-widget_type="divider.default">
				<div class="elementor-widget-container">
							<div class="elementor-divider">
			<span class="elementor-divider-separator">
						</span>
		</div>
						</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-b81be16 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="b81be16" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-78933a5" data-id="78933a5" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-a3d6048 elementor-widget elementor-widget-heading" data-id="a3d6048" data-element_type="widget" data-e-type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h4 class="elementor-heading-title elementor-size-default">Filipa`s Story</h4>				</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-a4fde48 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="a4fde48" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-38cefe5" data-id="38cefe5" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-df539e4 elementor-widget elementor-widget-text-editor" data-id="df539e4" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p>Hi everyone,</p><p>I was diagnosed with myeloma at 29 years old, and I would like to share my experience with medically induced menopause with all of you.</p><p>Before my stem cell transplant, my doctors explained the different side effects I could experience from the high-dose chemotherapy. However, it wasn’t until I actually experienced them myself that I truly understood what induced menopause meant and the impact it could have on my body, my mind and my self-esteem.</p><p>The first sign was the loss of my period. I had my last cycle a few days after my transplant and that was the last time I saw it. Then came the sudden hot flashes and night sweats, vaginal dryness that led to pain during sex, weight gain, difficulty concentrating and mood swings. It felt overwhelming. I was already trying to cope with this diagnosis and everything that came with it, and suddenly I was also dealing with changes that made me feel like I no longer recognised my own body. Slowly, I also started to realise that becoming a mother after all of this would be extremely difficult, even though I had frozen my eggs before treatment. That was another very painful thing to process.</p><p>When I first shared what I was experiencing with my doctor, I felt dismissed and ignored. And this is really difficult to talk about. But I was so uncomfortable and so unhappy with the way I was feeling that I decided to share all my symptoms again at my next appointment. I will never forget what he told me: “Young lady, it was us who did that terrible thing to you…”</p><p>Although I understood that the treatment had caused these changes, what I needed at that moment was empathy and support. Instead, there was no advice or discussion about possible ways of managing my symptoms. It felt as though menopause was something I simply had to accept and put up with, and that eventually it would all go away. But I was struggling a lot.</p><p>What really helped me during that period was reaching out to my support network. I had several sessions with my psychologist and most importantly, I reached out to other people who had gone through similar experiences. In particular, I had a friend my age who had been diagnosed with breast cancer and was going through many of the same changes. We shared our struggles, talked openly about things that were sometimes difficult to say out loud and exchanged tips on how to cope with them. Knowing that I wasn’t alone made a huge difference.</p><p>Four years have now passed, and I am doing well. Looking back, I wish I had known that I didn’t have to simply accept all of these symptoms as something I had to endure.</p><p>So, my advice to all of you is: if you are struggling, please speak up and ask for help. You don&#8217;t have to suffer in silence just because something is a consequence of cancer treatment. Talk to your medical team, ask about options for managing your symptoms, and don’t be afraid to seek a second opinion if you feel that your concerns are not being heard. Reach out to your family and friends, psychologists, patient advocates or patient organisations. And, if possible, connect with other young people who have gone through something similar.</p><p>You deserve to be heard, supported and cared for.</p><p>Stay strong</p>								</div>
				</div>
				<div class="elementor-element elementor-element-92fb323 elementor-widget-divider--view-line elementor-widget elementor-widget-divider" data-id="92fb323" data-element_type="widget" data-e-type="widget" data-widget_type="divider.default">
				<div class="elementor-widget-container">
							<div class="elementor-divider">
			<span class="elementor-divider-separator">
						</span>
		</div>
						</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-be8a03a elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="be8a03a" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2e185a4" data-id="2e185a4" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-96cc87e elementor-widget elementor-widget-text-editor" data-id="96cc87e" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p><strong>Need support or want to learn more?</strong></p><p>Join our upcoming EYMPG meeting on <strong>17 September 2026</strong> about <strong>Induced menopause and sexual health in young myeloma patients.</strong></p><p>Register here: <a href="https://forms.cloud.microsoft/e/ZSFF1cRJdi">EYMPG &#8211; Online Meeting Registration Form – Fill in form</a></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://www.mpeurope.org/a-young-patients-experience-of-induced-menopause-after-myeloma-treatment/">A young patient’s experience of induced menopause after myeloma treatment</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.mpeurope.org/a-young-patients-experience-of-induced-menopause-after-myeloma-treatment/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>MPE Advocate helps launch Luxembourg&#8217;s first myeloma information day</title>
		<link>https://www.mpeurope.org/strong-turnout-for-luxembourgs-myeloma-information-day/</link>
					<comments>https://www.mpeurope.org/strong-turnout-for-luxembourgs-myeloma-information-day/#respond</comments>
		
		<dc:creator><![CDATA[Adam Davenport]]></dc:creator>
		<pubDate>Tue, 30 Jun 2026 10:32:17 +0000</pubDate>
				<category><![CDATA[MPE]]></category>
		<guid isPermaLink="false">https://www.mpeurope.org/?p=116375</guid>

					<description><![CDATA[<p>The post <a href="https://www.mpeurope.org/strong-turnout-for-luxembourgs-myeloma-information-day/">MPE Advocate helps launch Luxembourg&#8217;s first myeloma information day</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="116375" class="elementor elementor-116375" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-419e78a elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="419e78a" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-902b317" data-id="902b317" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-2f0be56 elementor-widget elementor-widget-the7_photo-scroller" data-id="2f0be56" data-element_type="widget" data-e-type="widget" data-widget_type="the7_photo-scroller.default">
				<div class="elementor-widget-container">
							<div class="photo-scroller the7_photo-scroller-2f0be56 fullscreen-on hide-thumbs" data-scale="fill" data-autoslide="false" data-play-on-hover="false" data-delay="5000" data-show-thumbnails="true" data-thumb-position="inside-hidden" data-thumb-height="60" data-thumb-width="60" data-thumb-space="5" data-thumb-padding-top="5" data-thumb-padding-bottom="5" data-cntr-space-bottom="5" data-transparency="0.15" data-arrows="true" data-arrows_tablet="true" data-arrows_mobile="true" data-next-icon="fas fa-chevron-right" data-prev-icon="fas fa-chevron-left" data-r-arrow-v-position="center" data-r-arrow-h-position="right" data-l-arrow-v-position="center" data-l-arrow-h-position="left" data-ls-fill-dt="fill" data-ls-fill-tablet="fill" data-pt-fill-dt="fit" data-pt-fill-tablet="fit" data-pt-fill-mob="fit" data-ls-fill-mob="fill" data-padding-top="0" data-padding-bottom="0" data-padding-side="0" data-padding-left="0" data-t-padding-top="0" data-t-padding-bottom="0" data-t-padding-side="0" data-t-padding-left="0" data-m-padding-top="0" data-m-padding-bottom="0" data-m-padding-side="0" data-m-padding-left="0" data-ls-max="100" data-t-ls-max="100" data-m-ls-max="100" data-ls-min="0" data-t-ls-min="0" data-m-ls-min="0" data-pt-max="100" data-t-pt-max="100" data-m-pt-max="100" data-pt-min="0" data-t-pt-min="0" data-m-pt-min="0" data-height="300" data-tablet-height="300" data-mobile-height="300">
			<div class="photoSlider ">
				<figure data-width="1165" data-height="1600"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/06/The-4-speakers-at-Info-Day-plus-me.jpg "<a href="https://www.mpeurope.org/wp-content/uploads/2026/06/The-4-speakers-at-Info-Day-plus-me.jpg" class="post-thumbnail-rollover layzr-bg" title="The 4 speakers at Info Day plus Elizabeth"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%201165%201600&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/06/The-4-speakers-at-Info-Day-plus-me.jpg" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/06/The-4-speakers-at-Info-Day-plus-me.jpg 1165w" loading="eager" style="--ratio: 1165 / 1600" sizes="(max-width: 1165px) 100vw, 1165px" class="preload-me photo-thumb-lazy-load aspect" width="1165" height="1600"  alt="The 4 speakers at Info Day plus Elizabeth" title="The 4 speakers at Info Day plus Elizabeth" /></a></a></figure><figure data-width="2220" data-height="2560"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/06/MPE-photo-scaled.jpg "<a href="https://www.mpeurope.org/wp-content/uploads/2026/06/MPE-photo-scaled.jpg" class="post-thumbnail-rollover layzr-bg" title="MPE photo"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%202220%202560&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/06/MPE-photo-scaled.jpg" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/06/MPE-photo-scaled.jpg 2220w" loading="eager" style="--ratio: 2220 / 2560" sizes="(max-width: 2220px) 100vw, 2220px" class="preload-me photo-thumb-lazy-load aspect" width="2220" height="2560"  alt="AF3M and VFKM" title="MPE photo" /></a></a></figure><figure data-width="2560" data-height="1920"><a href=" https://www.mpeurope.org/wp-content/uploads/2026/06/90-participants-at-Info-day-scaled.jpg "<a href="https://www.mpeurope.org/wp-content/uploads/2026/06/90-participants-at-Info-day-scaled.jpg" class="post-thumbnail-rollover layzr-bg" title="90 participants at Info day"  aria-label="Post image"><img decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%202560%201920&#39;%2F%3E" data-src="https://www.mpeurope.org/wp-content/uploads/2026/06/90-participants-at-Info-day-scaled.jpg" data-srcset="https://www.mpeurope.org/wp-content/uploads/2026/06/90-participants-at-Info-day-scaled.jpg 2560w" loading="eager" style="--ratio: 2560 / 1920" sizes="(max-width: 2560px) 100vw, 2560px" class="preload-me photo-thumb-lazy-load aspect" width="2560" height="1920"  alt="90 participants at Info day" title="90 participants at Info day" /></a></a></figure>			</div>
			<div class="btn-cntr">
				<a href="#" class="hide-thumb-btn"></a>
				<a href="#" class="auto-play-btn"></a>
				<a href="#" class="full-screen-btn"></a>
			</div>
			<div class="scroller-arrow prev" role="button" tabindex="0" aria-label="Prev slide"><i aria-hidden="true" class="fas fa-chevron-left"></i></div>
			<div class="scroller-arrow next"  role="button" tabindex="0" aria-label="Next slide"><i aria-hidden="true" class="fas fa-chevron-right"></i></div>
		</div>
						</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-4ccc410 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="4ccc410" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f5df942" data-id="f5df942" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-910f6c9 elementor-widget elementor-widget-text-editor" data-id="910f6c9" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p>On 6 June 2026, over 90 patients, relatives and healthcare professionals gathered in Luxembourg for the country’s first dedicated myeloma information day, a clear sign of the growing demand for reliable, patient-centred information about the disease. The event was the result of an unlikely conversation. Elizabeth Collinge, a myeloma patient advocate who completed the MPE Advocate Development Programme (ADP) in 2024, recalled how she had floated the idea to Dr. de Wilde, Head of Haemato-Oncology at Luxembourg’s Centre Hospitalier, during a cocktail reception. Dr. de Wilde, who opened the conference with characteristic good humour, joked that she had only agreed to organise it after a few glasses of champagne.</p><p>Since completing the MPE ADP, Elizabeth has become a leading advocate for the myeloma community in Luxembourg. Working in partnership with the Cancer Foundation, she helped establish a dedicated myeloma patient support group, has spoken on English-language radio to raise awareness of myeloma symptoms and in March 2026 addressed an audience of several thousand people at Luxembourg’s annual Relay for Life fundraising event.</p><p>Her opening remarks set the tone for the day. Elizabeth underlined the importance of patients understanding their disease and treatment options so they can participate actively in shared decision-making and communicate confidently with their healthcare teams. She also spoke about the wider role of patient organisations, including ensuring the patient voice is represented in clinical trials and in discussions with regulatory bodies such as the European Medicines Agency (EMA).</p><p>The clinical programme was led by Dr. de Wilde, who gave an overview of major recent advances in myeloma treatment, including bispecific antibodies and CAR T-cell therapies. Alongside her, a psychologist, dietitian and physiotherapist each addressed a different dimension of living with myeloma, covering emotional well-being, nutrition and adapted physical activity respectively.</p><p>The event also brought an important European dimension. Georg Raida of VFKMMMPA and Valentine Baheux of AF3M, representing German and French myeloma patient associations, travelled to Luxembourg to take part, sharing their experiences with attendees over a buffet lunch and enriching the day with perspectives from neighbouring patient communities. This collaboration came about from Elizabeth networking at the recent MPE 2026 Masterclass in Lisbon, where she approached other members about joining this event.<br /><br />The morning concluded with a lively round-table discussion, with particular interest from participants in cilta-cel CAR-T therapy, which had recently been approved for reimbursement in Luxembourg.</p><p>The success of Luxembourg’s first Myeloma Information Day demonstrates how the MPE Advocate Development Programme empowers patients to become effective advocates and catalysts for change within their national communities.<br /><br />The day demonstrated what is possible when patients, healthcare professionals, industry and patient organisations come together to share knowledge, experience and support and suggested that Luxembourg’s myeloma community is ready to build on this strong foundation.</p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://www.mpeurope.org/strong-turnout-for-luxembourgs-myeloma-information-day/">MPE Advocate helps launch Luxembourg&#8217;s first myeloma information day</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.mpeurope.org/strong-turnout-for-luxembourgs-myeloma-information-day/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Supporting those who care: Introducing the MPE Care Connect Programme</title>
		<link>https://www.mpeurope.org/supporting-those-who-care-introducing-the-mpe-care-connect-programme/</link>
					<comments>https://www.mpeurope.org/supporting-those-who-care-introducing-the-mpe-care-connect-programme/#respond</comments>
		
		<dc:creator><![CDATA[Adam Davenport]]></dc:creator>
		<pubDate>Thu, 25 Jun 2026 09:50:38 +0000</pubDate>
				<category><![CDATA[MPE]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Carers]]></category>
		<category><![CDATA[member support]]></category>
		<guid isPermaLink="false">https://www.mpeurope.org/?p=116354</guid>

					<description><![CDATA[<p>Myeloma Patients Europe (MPE) is proud to announce the launch of the Care Connect Programme, a new initiative dedicated to strengthening support for carers of people living with myeloma and AL amyloidosis across Europe.  Carers play a vital role in the lives of patients, providing emotional support, practical assistance, care coordination, and advocacy throughout the myeloma pathway. However, feedback from MPE member organisations has&#8230;</p>
<p>The post <a href="https://www.mpeurope.org/supporting-those-who-care-introducing-the-mpe-care-connect-programme/">Supporting those who care: Introducing the MPE Care Connect Programme</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="116354" class="elementor elementor-116354" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-ada5d3b elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="ada5d3b" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a88fd1c" data-id="a88fd1c" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-978840c elementor-widget elementor-widget-image" data-id="978840c" data-element_type="widget" data-e-type="widget" data-widget_type="image.default">
				<div class="elementor-widget-container">
															<img decoding="async" width="1024" height="256" src="https://www.mpeurope.org/wp-content/uploads/2026/06/Slide1-e1782380659962-1024x256.jpg" class="attachment-large size-large wp-image-116359" alt="A line drawing of someone with their arm around another person" srcset="https://www.mpeurope.org/wp-content/uploads/2026/06/Slide1-e1782380659962-1024x256.jpg 1024w, https://www.mpeurope.org/wp-content/uploads/2026/06/Slide1-e1782380659962-300x75.jpg 300w, https://www.mpeurope.org/wp-content/uploads/2026/06/Slide1-e1782380659962-768x192.jpg 768w, https://www.mpeurope.org/wp-content/uploads/2026/06/Slide1-e1782380659962.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" />															</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-1f558de elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="1f558de" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-97bb9ac" data-id="97bb9ac" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-6683953 elementor-widget elementor-widget-text-editor" data-id="6683953" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p><span data-contrast="auto">Myeloma Patients Europe (MPE) is proud to announce the launch of the </span><b><span data-contrast="auto">Care Connect Programme</span></b><span data-contrast="auto">, a new initiative dedicated to strengthening support for carers of people living with myeloma and AL amyloidosis across Europe.</span><span data-ccp-props="{}"> </span></p><p><span data-contrast="auto">Carers play a vital role in the lives of patients, providing emotional support, practical assistance, care coordination, and advocacy throughout the myeloma pathway. However, feedback from MPE member organisations has highlighted a significant need for more educational resources, organisational support, peer-to-peer connection and recognition for carers at both national and European levels.</span></p><p>MPE’s <a href="https://www.mpeurope.org/about-mpe/our-goals/"><span data-contrast="none">strategic goals 2025 &#8211; 2030</span></a><span data-contrast="auto"> set out our clear commitment to “identify and address the needs of carers.” As part of this commitment, the Care Connect Programme will:</span><span data-ccp-props="{}"> </span></p><ul><li aria-setsize="-1" data-leveltext="" data-font="Wingdings" data-listid="2" data-list-defn-props="{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Wingdings&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}" data-aria-posinset="1" data-aria-level="1"><span data-contrast="auto">Support the development of national carer initiatives</span><span data-ccp-props="{}"> </span></li></ul><ul><li aria-setsize="-1" data-leveltext="" data-font="Wingdings" data-listid="2" data-list-defn-props="{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Wingdings&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}" data-aria-posinset="2" data-aria-level="1"><span data-contrast="auto">Launch the </span><a href="https://www.mpeurope.org/what-we-do/capacity-building-advocacy/care-connect-programme/"><span data-contrast="none">Care Connect Grants Programme</span></a><span data-contrast="auto"> for MPE members</span><b><span data-contrast="auto"> – now open for applications</span></b><span data-ccp-props="{}"> </span></li></ul><ul><li aria-setsize="-1" data-leveltext="" data-font="Wingdings" data-listid="2" data-list-defn-props="{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Wingdings&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}" data-aria-posinset="3" data-aria-level="1"><span data-contrast="auto">Develop dedicated information resources for carers</span><span data-ccp-props="{}"> </span></li></ul><ul><li aria-setsize="-1" data-leveltext="" data-font="Wingdings" data-listid="2" data-list-defn-props="{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Wingdings&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}" data-aria-posinset="4" data-aria-level="1"><span data-contrast="auto">Advance carer-focused research</span><span data-ccp-props="{}"> </span></li></ul><ul><li aria-setsize="-1" data-leveltext="" data-font="Wingdings" data-listid="2" data-list-defn-props="{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Wingdings&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}" data-aria-posinset="5" data-aria-level="1"><span data-contrast="auto">Strengthen policy and advocacy efforts for carers in Europe</span><span data-ccp-props="{}"> </span></li></ul><p><i><span data-contrast="auto">“We as carers or advocates for our loved ones must always keep in mind that we are accompanying someone on a long and complex road ahead and it is important to maintain and sustain our wellbeing and quality of life to be able to improve comfort and quality of life for our loved ones,</span></i><i><span data-contrast="auto">” </span></i><span data-contrast="auto">said</span><i><span data-contrast="auto"> </span></i><span data-contrast="auto">MPE Vice President of the Board and Carer, Diane Loening-Martens.</span><span data-ccp-props="{}"> </span></p><p><span data-contrast="auto">Diane also highlighted the sudden change in roles that accompanies a diagnosis. </span><span data-ccp-props="{}"> </span></p><p><i><span data-contrast="auto">“A myeloma diagnosis is a life altering event. From the moment of diagnosis, the future expectations, daily routines and relationship dynamics of both the person who has just received the diagnosis and their loved ones shift completely,”</span></i><span data-contrast="auto"> she said. </span><i><span data-contrast="auto">“Maybe partners or family members don’t call themselves carers, but in fact if they are giving emotional, physical and psychological support to their loved one, they are playing the role of a carer, supporter or companion.”</span></i><i><span data-contrast="auto"> </span></i><span data-ccp-props="{}"> </span></p><p><span data-contrast="auto">Through the Care Connect Programme, MPE aims to build stronger support systems for carers, facilitate knowledge sharing between organisations and ensure that carers are recognised as essential partners in healthcare.</span><span data-ccp-props="{}"> </span></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-096ce3d elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="096ce3d" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-c437e3f" data-id="c437e3f" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-c488624 elementor-widget elementor-widget-image" data-id="c488624" data-element_type="widget" data-e-type="widget" data-widget_type="image.default">
				<div class="elementor-widget-container">
															<img loading="lazy" decoding="async" width="1024" height="576" src="https://www.mpeurope.org/wp-content/uploads/2026/06/Slide2-1024x576.jpg" class="attachment-large size-large wp-image-116360" alt="Photo of people with their arm around another" srcset="https://www.mpeurope.org/wp-content/uploads/2026/06/Slide2-1024x576.jpg 1024w, https://www.mpeurope.org/wp-content/uploads/2026/06/Slide2-300x169.jpg 300w, https://www.mpeurope.org/wp-content/uploads/2026/06/Slide2-768x432.jpg 768w, https://www.mpeurope.org/wp-content/uploads/2026/06/Slide2.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" />															</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://www.mpeurope.org/supporting-those-who-care-introducing-the-mpe-care-connect-programme/">Supporting those who care: Introducing the MPE Care Connect Programme</a> appeared first on <a href="https://www.mpeurope.org">Myeloma Patients Europe</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.mpeurope.org/supporting-those-who-care-introducing-the-mpe-care-connect-programme/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
